Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis

Publisher： Karger

E-ISSN： 1421-9735|44|2|122-128

ISSN： 0253-5068

Source： Blood Purification, Vol.44, Iss.2, 2017-05, pp. : 122-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fibroblast Growth Factor 23 Predicts All-Cause Mortality in a Dose-Response Fashion in Pre-Dialysis Patients with Chronic Kidney Disease

By  

American Journal of Nephrology, Vol. 45, Iss. 2, 2016-12 ,pp. : 149-159

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 and Vascular Calcification: Is It Set in Stone?

By  

American Journal of Nephrology, Vol. 42, Iss. 6, 2015-0 ,pp. : 389-390

Karger

Access to resources Recommend Favorite

Relationship of Fibroblast Growth Factor 23 with Left Ventricle Mass Index and Coronary Calcificaton in Chronic Renal Disease

By  

Kidney and Blood Pressure Research, Vol. 36, Iss. 1, 2012-08 ,pp. : 55-64

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 4, 2009-10 ,pp. : 276-283

Karger

Access to resources Recommend Favorite

The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers

By  

Nephron Extra, Vol. 3, Iss. 1, 2013-11 ,pp. : 106-112

Karger

Access to resources Recommend Favorite